Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What ever you say. U da man!
Yea Generic competition in 2032!
Not updated. There are 25 per PR.on 12/19 I believe..
$1.72 EOY!!!!!!!!
LMAO!
Prurisol has a composition of matter patent.
One of the strongest types of patents.
A little light reading.
http://inventingpatents.com/composition-matter-claims/
Prurisol patent is ROCK SOLID.
Just review it. Pretty simple to understand.
https://www.google.com/patents/WO2013103601A1?cl=en
Karin I said the 400mg(27) is the same size as all the arms in the Phase2 study of 115 patients..
400mg sample size is the SAME size as ALL arms of phase2.
Great results and no sae's in 400mg arm then guess what Phase3 will look like:)
Blue Fin you are correct. $5B is squat. Now add in OM/UP results.
By the end of Feb K(OC) will have already started.
All 189 P patients will have been dosed and 2-3 weeks of patients will have completed their 12 weeks with visible results seen by many.
There will be a PLeaki.
$1.30 is a wee low SeptM.
We will have Interim OM data before P interim data.
Can't wait for that!!!
So the interim data will contain all 189 patients?
How bout dat:)
From the company blog...Tic Toc
http://www.cellceutix.com/new-blog/2017/1/6/bloomberg-biotech-deals-expected-to-bounce-in-2017
Who develops a loser IV cancer drug in to a pill?
Him and me both!
grizzly since they are running a 2a against almost impossible to treat Ovarian cancer I think POTENT is correct.
That sounds like a BIG Pharma company!!!
IMPRESSIVE!!!!!
1 thing is for certain
You can't get the 3-5 years without a 505 designation and Prurisol has one.
only death and taxes are certain..
I guess ???? was a tos violation. So rr what is in that video for US?
505 can get you 3-5 more years of market exclusivity.
The 505 gets it to market a lot quicker for a lot longer...
ARia 200m rev sold for %5.2B
That's 25 x sales...Your anomaly was just repeated.
justfactsman that's 40 x sales,,,Abbvie only gets 1/2 the sales of Imbruvica...Jannsen gets the other 1/2..
Yup you are right. Just another year i the $ range...UNREAL!
We were talking interim (6 week data).
Trial is only 2 months old today:)
Brady maybe you need to read the entire article.
https://www.biospace.com/News/cambridges-merrimack-slashes-80-of-workforce-sells/443592/source=TopBreaking
so it's not LATE 2nd qtr...
not my slide...
ABSOLUTELY....
septmike Where do you see interim data LATE 2nd qtr?
Septmike we are in Early January...
""Cellceutix Actively Discussing Partnerships for Late-Stage Studies"
This says it all
""Cellceutix Actively Discussing Partnerships for Late-Stage Studies"
Jhawker why is K the riskiest?
Because it's behind the other candidates?
It did pretty damn good at Dana Farber Phase1.
It's all about making deals on the potential of your drugs...I could care less about when they get approved.
They are being conservative...No doubt...